Diana Nitusca

TL;DR: Data is provided indicating that miR-150-5p plasma variations in PCa patients are associated with concordant changes in prostate cancer tissues; however, given the heterogeneous nature of previous findings, additional future studies of a larger sample size are warranted in order to confirm the biomarker potential and role of miRNAs or miRs in PCA biology.

TL;DR: In this article, an untargeted metabolomic profiling performed in plasma samples of 11 major depressive disorder patients, at baseline and at 12 weeks following antidepressant therapy with escitalopram (MDD2), and in 11 healthy controls (C), using ultra-high performance liquid chromatography coupled with electrospray ionization-quadrupole-time of flight-mass spectrometry (UHPLC-QTOF-(ESI+)-MS).

TL;DR: In this paper, the potential biomarker role of several candidate microRNA species (miRs) for major depressive disorder (MDD), as well as treatment response monitoring indicators, in order to enrich the current knowledge and facilitate possible diagnostic biomarker development for MDD.

TL;DR: In this paper, the authors conducted lncRNA profiling in plasma and microdissected formalin-fixed paraffin-embedded (FFPE) tissues of prostate cancer patients and attempted validation for commonly dysregulated individual lncRNAs.

TL;DR: In this paper, the impact of body weight (BMI) increase on the biological treatment of psoriasis was investigated, to further investigate on its relationship with the disease and aid the management of treatment schemes that take into account individual characteristics of patients, such as body mass, for a more efficient and personalized therapy approach.